Actively Recruiting

Age: 1Week - 100Years
All Genders
NCT06019182

MEHMO Natural History and Biomarkers

Led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Updated on 2026-04-27

150

Participants Needed

1

Research Sites

1558 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational natural history study will follow individuals with MEHMO (Mental disability, Epileptic seizure, Hypopituitarism/Hypogenitalism, Microcephaly, Obesity) syndrome or an eIF2-pathway related disorder, who have symptoms such as intellectual delay, seizures, abnormal hormone and blood sugar levels, and decreased motor skills. No current treatment for these conditions is available. A major impediment to the testing of potential therapeutic interventions is the lack of well-defined outcome measures. This protocol seeks to identify biochemical and clinical markers to monitor disease progression, and better understand the natural history of these conditions. Any person diagnosed with MEHMO syndrome or related conditions, who can travel to the NIH Clinical Center can participate in this study. The study involves: * General health assessment and evaluation * Imaging studies * Laboratory tests * Collection of blood, urine, spinal fluid, skin biopsy.

CONDITIONS

Official Title

MEHMO Natural History and Biomarkers

Who Can Participate

Age: 1Week - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be at least 1 week old if affected by MEHMO syndrome or related condition
  • Be at least 1 month old if unaffected
  • For screening, have signs or symptoms suggestive of MEHMO syndrome with no or inconclusive molecular testing, or be a relative of someone with MEHMO syndrome/eIF2-related condition with informative genetics
  • For main study, have signs or symptoms suggestive of MEHMO syndrome and have disease-associated or uncertain variant(s) in eIF2-pathway genes
  • Or be a relative carrier of a pathogenic or likely pathogenic variant
  • Or be a non-affected, non-carrier family member of someone with MEHMO syndrome or related condition
Not Eligible

You will not qualify if you...

  • Individuals unable to comply with the study protocol
  • Individuals with medical conditions that may increase risks of participation, as judged by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

A

An N Dang Do, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here